MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 62 filers reported holding MARRONE BIO INNOVATIONS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | +25.0% | 4,928 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -20.0% | 4,928 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 4,928 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 4,928 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -20.0% | 4,928 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -28.6% | 4,928 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | -12.5% | 4,928 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +14.3% | 4,928 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -22.2% | 4,928 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | 0.0% | 4,928 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | – | 4,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 18,335,767 | $19,803,000 | 3.30% |
| Shay Capital LLC | 2,500,083 | $2,700,000 | 0.35% |
| OAK FAMILY ADVISORS, LLC | 400,726 | $433,000 | 0.17% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 709,229 | $766,000 | 0.14% |
| EHP Funds Inc. | 651,679 | $704,000 | 0.12% |
| Alpine Global Management, LLC | 487,272 | $526,000 | 0.06% |
| FNY Investment Advisers, LLC | 45,000 | $48,000 | 0.04% |
| Ergoteles LLC | 906,130 | $979,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 148,477 | $160,000 | 0.02% |
| Long Focus Capital Management, LLC | 100,000 | $108,000 | 0.01% |